Acadia Healthcare reported a strong start to 2021, with revenue increasing by 8.2% to $551.2 million. The company's same facility revenue grew by 7.4%, and adjusted EBITDA was $119.5 million. Acadia is focused on strategic investments in facility expansions, de novo facilities, and joint venture partnerships to drive long-term growth.
Revenue increased by 8.2% to $551.2 million compared to Q1 2020.
Same facility revenue grew by 7.4% compared to Q1 2020.
Adjusted EBITDA was $119.5 million, compared to $96.7 million in the same period last year.
The company completed debt refinancing actions in March 2021.
Acadia increased its financial guidance for 2021.
Analyze how earnings announcements historically affect stock price performance